Your Product

Your Product

Back to main menu

Your Product

Services tailored to your product, ensuring the right development path, scalable processes, and consistent manufacturing outcomes.

Learn more
Your Stage

Your Stage

Back to main menu

Your Stage

At each stage, new challenges emerge. A single team and site ensure continuity and consistent execution across the product lifecycle.

Learn more
Our Services

Our Services

Back to main menu

Our Services

Integrated CDMO services designed for seamless progression from development through commercial manufacturing, under global regulatory standards.

Learn more
Resources

Resources

Back to main menu

Resources

Technical insights, practical guidance, and applied expertise to support decision‑making at every stage.

See all resources
About Us

About Us

Back to main menu

About Us

An overview of Groupe PARIMA, our mission, and our expertise in supporting the pharmaceutical industry.

Learn more
    En
    English
    Contact us

    process validation

    We deliver process validation through defined acceptance criteria, controlled PPQ
    execution, and submission-ready documentation.

    Drug Manufacturing banner

    From Knowledge to Consistent Execution 

    We translate development and scale-up knowledge into a qualified, repeatable GMP process.

    Groupe PARIMA plans and executes process validation with approved protocols, defined CPPs and CQAs, and completes GMP documentation for submission-ready outcomes. From PPQ strategy through data review and final reports, we help teams move into commercial manufacturing with clarity, control, and traceable evidence.

    Talk to our experts

    From protocol to final report, Groupe PARIMA runs process validation with full traceability and quality oversight.

    Process Validation Expertise

    We combine development insight, GMP execution, and quality oversight to deliver validation evidence that supports reliable manufacturing and regulatory submissions.

    Card 01

    Validation strategy and protocols

    Clear PPQ plans, acceptance criteria, and sampling rationales aligned to your product, process, and filing pathway.

    Card 02

    Control strategy built on risk

    Defined CQAs and CPPs translated into in-process controls, IPC limits, and practical batch instructions for consistent performance.

    Card 03

    PPQ Strategy & Protocols

    We define the PPQ approach, acceptance criteria, and sampling plan to support coordinated qualification execution, deviation control, and traceability.

    Card 04

    Analytical readiness & data integrity

    Stability-indicating and release methods applied with a fit-for-purpose sampling plan and defensible data review.

    Card 05

    Submission-ready documentation

    Complete validation reports that connect process history, batch results, statistical treatment, and conclusions into an audit-ready package.

    Validation capabilities for GMP readiness

    Groupe PARIMA executes process validation for non-sterile drug products with clear protocols, disciplined batch execution, and submission-ready documentation.

    01
    Card 01

    Preparation for PPQ

    We prepare for PPQ by aligning process parameters, controls, and documentation to ensure readiness for consistent commercial performance.

    02
    Card 02

    GMP PPQ batch execution

    We run qualification batches with controlled manufacturing and packaging operations supported by Quality oversight and traceable records.

    03
    Card 03

    Validation Lifecycle

    We compile, trend, and interpret PPQ results to demonstrate process capability and support clear conclusions.

    Resources

    Access practical resources on process validation strategy, PPQ evidence, and continued process verification.

    Groupe PARIMA
    How Drug Product Formulation Works: Topical, Oral, and Nasal Liquid and Semi-Solid Dosage Forms
    Read more
    Groupe PARIMA
    How Early API Characterization Can Reduce Formulation and Scale-up Risks
    Read more
    Groupe PARIMA
    Topical 101: A Guide to Complex Dermatology Formulation Development
    Read more
    Groupe PARIMA
    How Drug Product Formulation Works: Topical, Oral, and Nasal Liquid and Semi-Solid Dosage Forms
    Read more
    Groupe PARIMA
    How Early API Characterization Can Reduce Formulation and Scale-up Risks
    Read more
    Groupe PARIMA
    Topical 101: A Guide to Complex Dermatology Formulation Development
    Read more

    See all Resources

    Contact us

    Turn process understanding into proven control

    Let’s align your validation plan, batch execution, and reporting to keep your program moving toward commercialization.